GSK Forks Up $105M To End States' Off-Label Marketing Suits
GlaxoSmithKline PLC said on Wednesday it has reached settlements totaling $105 million with 44 states and the District of Columbia, resolving allegations that the company improperly marketed and promoted the asthma...To view the full article, register now.
Already a subscriber? Click here to view full article